SYMLIN Drug Patent Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which patents cover Symlin, and what generic alternatives are available?
Symlin is a drug marketed by Astrazeneca Ab and is included in one NDA.
The generic ingredient in SYMLIN is pramlintide acetate. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the pramlintide acetate profile page.
Summary for SYMLIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 11 |
Clinical Trials: | 20 |
Patent Applications: | 3,976 |
Drug Prices: | Drug price information for SYMLIN |
DailyMed Link: | SYMLIN at DailyMed |


Recent Clinical Trials for SYMLIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Institute on Aging (NIA) | Early Phase 1 |
Boston University | Early Phase 1 |
H. Lee Moffitt Cancer Center and Research Institute | Early Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for SYMLIN
US Patents and Regulatory Information for SYMLIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Astrazeneca Ab | SYMLIN | pramlintide acetate | INJECTABLE;SUBCUTANEOUS | 021332-002 | Sep 25, 2007 | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
Astrazeneca Ab | SYMLIN | pramlintide acetate | INJECTABLE;SUBCUTANEOUS | 021332-003 | Sep 25, 2007 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
Astrazeneca Ab | SYMLIN | pramlintide acetate | INJECTABLE;SUBCUTANEOUS | 021332-001 | Mar 16, 2005 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for SYMLIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Astrazeneca Ab | SYMLIN | pramlintide acetate | INJECTABLE;SUBCUTANEOUS | 021332-002 | Sep 25, 2007 | See Plans and Pricing | See Plans and Pricing |
Astrazeneca Ab | SYMLIN | pramlintide acetate | INJECTABLE;SUBCUTANEOUS | 021332-001 | Mar 16, 2005 | See Plans and Pricing | See Plans and Pricing |
Astrazeneca Ab | SYMLIN | pramlintide acetate | INJECTABLE;SUBCUTANEOUS | 021332-002 | Sep 25, 2007 | See Plans and Pricing | See Plans and Pricing |
Astrazeneca Ab | SYMLIN | pramlintide acetate | INJECTABLE;SUBCUTANEOUS | 021332-001 | Mar 16, 2005 | See Plans and Pricing | See Plans and Pricing |
Astrazeneca Ab | SYMLIN | pramlintide acetate | INJECTABLE;SUBCUTANEOUS | 021332-001 | Mar 16, 2005 | See Plans and Pricing | See Plans and Pricing |
Astrazeneca Ab | SYMLIN | pramlintide acetate | INJECTABLE;SUBCUTANEOUS | 021332-003 | Sep 25, 2007 | See Plans and Pricing | See Plans and Pricing |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for SYMLIN
See the table below for patents covering SYMLIN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Russian Federation | 2130463 | ANALOG-AGONIST OF AMYLINE, ITS PHARMACEUTICALLY ACCEPTABLE SALTS, COMPOSITION EXHIBITING PROPERTIES OF AMYLINE AGONIST | See Plans and Pricing |
Japan | 2828250 | See Plans and Pricing | |
Germany | 69231583 | See Plans and Pricing | |
Greece | 3035287 | See Plans and Pricing | |
European Patent Office | 0529065 | PROCEDES DE CRIBLAGE UTILISANT DES RECEPTEURS ET PERMETTANT LA DETECTION D'AGONISTES ET D'ANTAGONISTES DE L'AMYLINE (RECEPTOR-BASED SCREENING METHODS FOR AMYLIN AGONISTS AND ANTAGONISTS) | See Plans and Pricing |
Germany | 69426304 | See Plans and Pricing | |
>Country | >Patent Number | >Title | >Estimated Expiration |